NUCALA 100MG INJECTION

NUCALA 100MG INJECTION is not intended to replace other asthma medications, including inhalers or oral medications. It is typically used as an add-on treatment for individuals with severe eosinophilic asthma who require additional control of their symptoms. Your healthcare professional should discuss and determine the use of other asthma medications.

Discussing vaccination schedules and specific vaccines with your healthcare professional while on NUCALA 100MG INJECTION is recommended. It may affect the effectiveness of certain vaccines, particularly live vaccines. Your healthcare professional can guide the appropriate timing and administration of vaccinations.

Weight gain is not commonly reported as a side effect of NUCALA 100MG INJECTION. However, individual responses to medication can vary, and some may experience weight gain due to other factors. If you have concerns about weight changes while on taking it, discuss them with your healthcare professional.

The response to NUCALA 100MG INJECTION can vary among individuals. Some people may experience improved symptoms, such as reduced asthma exacerbations or improved lung function, within a few weeks of starting treatment. However, it may take several months to observe the full benefits of this medication. Regular follow-up with your healthcare professional is important to assess your response to treatment.

Considering their overall health and potential interactions with other medications, NUCALA 100MG INJECTION can be used in older adults with severe eosinophilic asthma or EGPA. However, individual assessment and monitoring by a healthcare professional are important to determine the suitability and safety of this medication in older adults.

Attend all scheduled appointments and follow-up visits to monitor your response to treatment and address any concerns or side effects. Tell your doctor about your medical history, any previous infection, liver disease, and kidney disease. Seek immediate medical attention if you experience severe allergic reactions or other serious side effects. Avoid close contact with an infected person. Do not change your NUCALA 100MG INJECTION treatment or corticosteroid dose without consulting your healthcare professional. Inform your doctor's provider about any changes or concerns.

The safety and efficacy of NUCALA 100MG INJECTION in children below six years of age have not been established. Avoid taking any vaccines during treatment unless specifically advised by your healthcare professional.

The active ingredient in NUCALA 100MG INJECTION is Mepolizumab.

NUCALA 100MG INJECTION is used to treat certain conditions like severe eosinophilic asthma and Eosinophilic Granulomatosis with Polyangiitis (EGPA).